This case series describes the medical management of four pregnant women with active multidrugresistant tuberculosis. None of the four patients were infected with human immunodeficiency virus. Three patients had disease due to multidrug-resistant Mycobacterium tuberculosis, and one had disease due to multidrug-resistant Mycobacterium bovis. Only one patient (patient 3) began retreatment during pregnancy, because her organism was susceptible to three antituberculosis drugs that were considered nontoxic to the fetus. Despite concern over teratogenicity of the second-line antituberculosis medications, careful timing of treatment initiation resulted in clinical cure for the mothers, despite some complications due to chronic tuberculosis and/or therapy. All infants were born healthy and remain free of tuberculosis. Pregnancy and multidrug-resistant tuberculosis need not be a public health disaster, as both conditions can be managed concurrently and successfully.
Tuberculosis in the United States once appeared to be headed vidualize treatments according to each patient's medical and psychosocial needs. toward elimination, since the annual number of new cases steadily declined from 1953 to the mid-1980s. However, the AIDS epidemic, immigration from countries with a high prevaMethods lence of tuberculosis, crowding and drug abuse in the inner cities, and dismantling of tuberculosis control programs be-
The MDR Tuberculosis Unit of the Tuberculosis Control cause of funding cuts contributed to an increased incidence of Program in Los Angeles County identifies (usually via laboratuberculosis between 1986 and 1992 [1 -3] . This in turn tory reports) all cases of MDR tuberculosis in its jurisdiction, prompted more funding for tuberculosis control programs, and then investigates and co-manages these cases with their respecseveral jurisdictions reported increasing use of directly obtive health care providers. After its inception in August 1993, served therapy (DOT) [4 -6] . These kinds of interventions are the MDR Tuberculosis Unit identified four pregnant women credited with the declining number of new cases since 1992. who had MDR tuberculosis. All medical records of the patients Interestingly, a review of records of two public hospitals in were reviewed, and each case was co-managed by the primary New York City indicated an increasing case rate of tuberculosis care provider in the public health clinic, the public health staff in pregnant women, from 5/40,388 (12.4/100,000) in 1985 -serving the patient's district of residence, and Tuberculosis 1990 to 11/11,595 (94.8/100,000) in 1991 -1992 [7] . This inControl Program consultants. Investigation of contacts included crease in tuberculosis among pregnant women occurred during each patient's health care providers. a time when outbreaks of multidrug-resistant (MDR) tuberculoManagement options were individualized according to each sis were occurring [8] . However, the authors could find no patient's medical needs and personal desires. Antituberculosis reports in the medical literature describing the management of medications were selected according to the susceptibility patpregnant women with MDR tuberculosis.
tern and treatment history of each patient, and treatment was Pregnancy complicates treatment of MDR tuberculosis for initiated when deemed safe for both the mother and fetus. the following reasons: Several antimycobacterial drugs are conPrenatal care of patients 1 -3 was done in negative-pressure traindicated during gestation, patients and physicians may fear respiratory isolation rooms, because their sputa were smearthe effects of chest radiography on the fetus, and untreated positive for acid-fast bacilli (AFB). Health care staff for all infectious MDR tuberculosis may be vertically and laterally patients followed the infection-control guidelines described by transmitted [9 -11] .
the Centers for Disease Control and Prevention (CDC) during This case series describes the management of four pregnant delivery and the postpartum period of all patients [11] . After patients with MDR tuberculosis. It illustrates the need to indidelivery, the placentas were examined to investigate the possibility of vertical transmission of tuberculosis. Infants whose mothers were infectious at delivery were separated from their multiple retreatment regimens. All patients were treated by None of the three patients who elected to carry their pregnancy to term chose to breast-feed. No evidence of tuberculosis transmeans of DOT and monitored for 2 years after completion of treatment. mission was found in the patients' health care providers. Because patients 1 and 2 were considered to be at high risk for treatment failure, their infants were immunized with BCG.
Results
Both infants received two doses of BCG vaccine, since the zone of induration on tuberculin skin testing after the first doses All four patients were HIV-negative, and all had acquired MDR tuberculosis through prior noncompliance with antituberremained 0 mm. BCG vaccine was not given to the infant of patient 3 because the patient's sputa were consistently cultureculosis treatment (although a prescribing error may have contributed to resistance in case 3). None of the patients were negative by the time of delivery; her infant's zone of induration on tuberculin skin testing measured 0 mm at birth and 3 months known to have ever lived in New York City. Demographic data, dates of initial diagnosis of tuberculosis, results of smears later. Although the children of patients 1 -3 remain healthy, those of patients 1 and 2 received preventive therapy because and cultures of sputa at the time of delivery, and susceptibility results (initial and just before retreatment) are described in they both had positive results on tuberculin skin testing ú1 year after their mothers became noninfectious. period that lasted 2 years after treatment. Their treatment regito be at high risk for treatment failure. Three months after the second dose of BCG vaccine, the infant's zone of induration mens, lengths of therapy, and reasons for discontinuing treatment are summarized in table 2.
on tuberculin skin testing measured 5 mm. Patient 1 began receiving treatment with ethambutol, cycloserine, para-aminosalicylic acid, capreomycin, ofloxaCase Reports cin, and clofazimine, all given as DOT. Although smears and cultures of her sputum for AFB yielded negative results in Patient 1 was a 25-year-old Hispanic woman (three pregnancies, no births, two abortions) who was first diagnosed with April 1994 , patient 1 chose to remain separated from her child until she was convinced she was noninfectious (2 years). In tuberculosis in Mexico in 1982. She immigrated to the United States in 1986, was not consistently adherent to antituberculosis June 1996, patient 1 completed 24 months of retreatment after cultures began yielding negative results, and although treatment, and was diagnosed with cavitary MDR tuberculosis in May 1987. Despite undergoing multiple retreatment attempts she remains cured of MDR tuberculosis, her posttreatment course was complicated. Two months after completing MDR over the years with regimens containing isoniazid, rifampin, pyrazinamide, ethambutol, streptomycin, ethionamide, cyclostuberculosis treatment, she was admitted to a hospital for hemoptysis and a new intracavitary density in her left lung. erine, para-aminosalicylic acid, capreomycin, kanamycin, ciprofloxacin, and clofazimine, testing of the patient's sputum Twelve samples of sputum were collected, and all were negative for AFB by both smear and culture except for one, which by smear and culture continued to yield positive results, and her organism acquired additional resistance. During multiple demonstrated moderate AFB on smear. The patient was diagnosed with possible relapsed MDR tuberculosis and her prior prior retreatment courses, the patient broke many clinic appointments, moved without notice, was transiently lost to foltreatment regimen was restarted; investigation of contacts was repeated. Testing of her immediate and extended family low-up, went to Mexico for herbal treatment, and was told she was ''cured'' by a physician in Mexico. She was found to be identified no one with tuberculosis, but the size of the zone of reaction to tuberculin skin testing of her child had inpregnant in April 1993, and although she had not completed two prior pregnancies and had contagious MDR tuberculosis, creased by 10 mm. Although this test result may have been due to boosting of the BCG reaction, the child was given she desired to carry this gestation to term. Antituberculosis treatment was withheld during gestation because her disease isoniazid preventive therapy because she lives in an area with a relatively high incidence of tuberculosis, and the increased was stable (although communicable), and another retreatment regimen would necessitate use of potentially teratogenic drugs.
size of the zone of induration met criteria for skin test conversion [12] . The solitary smear-positive sputum sample from Although patient 1 remained untreated during gestation, she adopted lifestyle changes that were subsequently shown by patient 1 later yielded drug-susceptible Mycobacterium tuberculosis on culture, and restriction fragment length polyinvestigation of contacts to have prevented tuberculosis transmission to her close contacts. Immediately after a normal vagimorphism analysis demonstrated a pattern identical to that of another patient who had been concurrently hospitalized. nal delivery in December 1993, the neonate was separated from her mother, whose sputa were positive for MDR tuberculosis Patient 1 was eventually diagnosed with pulmonary aspergillosis, which responded well to itraconazole. Four months by smear and culture. Before being discharged to the care of a relative who had been screened for tuberculosis, the baby after this episode, patient 1 had spontaneous right pneumothorax, requiring placement of a chest tube. She eventually was immunized with BCG because her mother was considered / 9c68$$ju37 05-11-99 12:36:55 cida UC: CID underwent surgical resection of a ruptured right apical cystic zone (previously 7 mm) now measured 15 mm, and while the increased size may have been due to boosting of the BCG lesion, and both she and her child are now well and free of tuberculosis.
reaction, the child was given isoniazid preventive therapy, since close contact with a highly infectious case placed him at high Patient 2 was a 29-year-old Hispanic woman (seven pregnancies, one birth, five abortions) who had diabetes mellitus and risk for recent infection. Patient 2 and her child remain free of tuberculosis to date. chronic hepatitis C virus infection and who immigrated to the United States from Mexico in 1970. She was diagnosed with Patient 3 was a 24-year-old Hispanic woman (two pregnancies, one birth, no abortions) who was born in California but pulmonary drug-susceptible tuberculosis in 1986; at that time she began the first of many self-administered antituberculosis who recalled being exposed to tuberculosis in Mexico. She was first diagnosed with cavitary pulmonary tuberculosis resisregimens to which she was nonadherent and that were frequently interrupted by trips to Mexico and numerous pregnantant to isoniazid in early 1994, at which time she was treated with a self-administered regimen of isoniazid, rifampin, and cies. In 1988, her organism demonstrated new resistance to isoniazid, and by 1991, new resistance to rifampin was also pyrazinamide. She was found to be pregnant in November 1994 and was allowed to continue self-administered medications denoted despite her receiving DOT. Her organism was later identified as M. bovis. The patient's prior treatment regimens inspite indications of nonadherence (e.g., frequently missed clinic appointments). By January 1995, her organism had acquired cluded isoniazid, rifampin, pyrazinamide, ethambutol, streptomycin, ethionamide, and capreomycin. Because of the frequent resistance to both isoniazid and rifampin, and her sputa were positive by both smear and culture. A new regimen of ethambuinterruptions in and nonadherence to her therapy, results of smear and culture testing of the patient's sputum samples retol, pyrazinamide, and ethionamide was begun, all given by daily DOT. Ethambutol was recommended because it is safe mained positive for M. bovis over the years, and in July 1993 she was found to be in the first trimester of another pregnancy.
for use in pregnancy, and pyrazinamide and ethionamide were used because there are no data indicating that they are teratoRetreatment was withheld during the pregnancy to avoid exposing the fetus to potentially teratogenic medications, and genic [14] . Cultures of sputum yielded negative results in April 1995 and continue to be negative to date. However, because the patient received a holding regimen of combination capsules containing rifampin and isoniazid (Rifamate; Marion Merrell sputum collected in June 1995 was positive for AFB by smear (although later found to be negative by culture), she was considDow, Kansas City, MO) to keep the tuberculosis from progressing [13] . After blood was found in the amniotic fluid on amnioered infectious during delivery. Thus, immediately after being delivered by normal vaginal delivery in July 1995, the baby centesis in February 1994, she underwent emergency cesarean section (followed by elective bilateral tubal ligation) and delivgirl was separated from her mother and began receiving a preventive regimen of pyrazinamide and ethambutol. The baby ered a healthy male infant, who was immediately separated from her because her sputum samples were positive for MDR was discharged home with her mother, because three sputum samples after delivery from patient 3 yielded negative results M. bovis by smear and culture. Before being discharged to the care of a relative who had been screened for tuberculosis, by smear. Preventive therapy was discontinued Ç3 months later when results of repeat tuberculin skin testing of the infant the baby was immunized with BCG, because her mother was considered to be at high risk for treatment failure. Three months were negative. Capreomycin and ofloxacin were added to the patient's retreatment regimen in the immediate postpartum peafter the second BCG dose, the infant's zone of induration on tuberculin skin testing measured 7 mm. riod, and she was repeatedly counseled on the importance of avoiding pregnancy while receiving the new retreatment regiPatient 2 began retreatment with high-dose isoniazid, ethambutol, ethionamide, cycloserine, amikacin, and ofloxacin immemen. Antituberculosis medications were discontinued in September 1996 (Ç17 months after cultures began yielding negadiately after delivery; except for isoniazid, all medications were continued by daily DOT after discharge from the hospital.
tive results) because the patient became pregnant again. She delivered a healthy male baby in March 1997, despite having Three months later (when her sputa were consistently negative for AFB by smear and culture), she returned home to her baby.
been receiving a quinolone-containing regimen during the first trimester. She and her children remain healthy to date. Patient 2 later underwent right pneumonectomy to remove a completely destroyed right lung that was determined to be a Patient 4 was a 30-year-old homeless black woman (three pregnancies, one birth, one abortion) who had a history of reservoir of drug-resistant organisms. Her postsurgical course was complicated by transient thrombocytopenia and an infected abusing alcohol and crack cocaine. She was diagnosed with cavitary pulmonary tuberculosis susceptible to drugs in March bronchopleural fistula that eventually required creation of an Eloesser flap, but she completed 2 years of retreatment after 1994 but was nonadherent to a self-administered regimen of isoniazid, rifampin, pyrazinamide, and ethambutol. Treatment cultures began yielding negative results and remains free of disease due to relapse. Unfortunately, in 1996, her child was was interrupted by her frequent moving and many broken appointments. Her organism developed resistance to isoniazid identified as a close contact of an uncle who acquired rifampinresistant cavitary pulmonary M. bovis because of nonadherence by August 1994, and although she began receiving DOT in November 1994, she was lost to follow-up soon thereafter. Her to prior preventive therapy. The child's tuberculin skin test / 9c68$$ju37 05-11-99 12:36:55 cida UC: CID sputa remained positive by culture despite treatment in jail In 1994, the patient was diagnosed with isoniazid-resistant tuberculosis and treated with isoniazid, rifampin, and pyrazinafrom March to August 1995, and she was treated with rifampin, ethambutol, and pyrazinamide given by DOT after her release.
mide. Isoniazid was probably ineffective since her organism was resistant to it, and pyrazinamide (a poor companion drug) Susceptibility testing on an organism obtained by culture of a sputum sample collected in late August 1995 demonstrated does not prevent the emergence of resistance to the effective agent [19] . If the treating physician in 1994 had not relied on resistance to isoniazid and new resistance to rifampin, but her regimen was not changed because of a newly diagnosed pregrifampin and pyrazinamide to treat isoniazid-resistant tuberculosis, patient 3 may not have developed MDR tuberculosis. nancy. She repeatedly stated her desire for a therapeutic abortion, which was done in November 1995, and she was thereafter
The treatment of most cases of MDR tuberculosis requires the use of second-line antituberculosis drugs that are generally treated with high-dose isoniazid, pyrazinamide, ethambutol, cycloserine, ofloxacin, and capreomycin, all given by daily less effective but more toxic than first-line drugs, and treatment regimens for MDR tuberculosis must be individualized ac-DOT. She completed 24 months of retreatment after cultures began yielding negative results, and she remains disease-free.
cording to the susceptibility pattern of the patient's pathogen [20] . The potential teratogenicity of the second-line drugs comUnfortunately, she refused drug rehabilitation services.
plicates the treatment of pregnant patients with MDR tuberculosis, for whom the risks of no treatment (including vertical Discussion and lateral transmission of tuberculosis), timing of initiation of treatment, and treatment risks must be carefully weighed. Even after the advent of chemotherapy for tuberculosis, the medical community disagreed on the bidirectional effects of Patients must be fully informed of their therapeutic options and must be actively involved in decision making. tuberculosis and pregnancy [15] . Therapeutic abortions were once recommended for women with tuberculosis, as pregnancy
The treatment of each case in this series was individualized accordingly. Patient 1 was not given any antituberculosis mediwas thought to be deleterious to the disease course. Studies have since indicated that the effect of pregnancy on tuberculosis cations during pregnancy because her disease had not been suppressed by an isoniazid holding regimen over the 2 years is minimal, if any. However, tuberculosis has potentially negative effects on pregnancy, including possible hematogenous preceding gestation, and most of her retreatment drugs were teratogenic. Serial susceptibility testing had shown her organspread through the umbilical vein, spread to the reproductive tract, and postpartum transmission to the infant and other close ism to be either resistant to ethambutol at only the lowest level tested or fully susceptible; therefore, ethambutol was included contacts [16] . Thus, it is currently recommended that pregnant women be treated for tuberculosis with nonteratogenic drugs in the retreatment regimen of patient 1. During gestation, patient 2 received combination medication containing both isoniasuch as isoniazid, rifampin, and ethambutol [12, 17] .
This case series illustrates the factors that contribute to the zid and rifampin because both are safe during pregnancy [17], and she had previously experienced bacteriologic suppression acquisition of MDR tuberculosis and the unique challenges presented by pregnancy and MDR tuberculosis. Factors contributing while receiving these drugs. Although susceptibility testing of an organism obtained by culture of sputum collected during to the development of MDR tuberculosis include failure of prior health care providers to give DOT and prescription of an inadegestation had shown isoniazid resistance at the highest level tested, prior serial susceptibility testing of isolates from patient quate treatment regimen. Management issues raised by these patients and their infants include the following: the teratogenic 2 had shown either low-level isoniazid resistance or full susceptibility; therefore, high-dose isoniazid was initially used to rerisks of second-line tuberculosis medications, the use of holding regimens consisting of isoniazid and/or rifampin, the timing of treat patient 2. Patient 3 was unique in that she began retreatment during gestation. She began to receive pyrazinamide, treatment initiation, risks of vertical and lateral transmission of MDR tuberculosis, BCG immunization of the infants, and postethambutol, and ethionamide during her second trimester because ethambutol is considered safe for pregnant women [12, treatment complications due to pulmonary MDR tuberculosis.
The tuberculosis organisms of the four patients in this series 17], and there are no data indicating that the other two drugs are teratogenic [14] . Her neonate is, in fact, healthy. For personal apparently acquired multidrug resistance because of the patients' prior nonadherence to self-administered antituberculosis reasons, patient 4 repeatedly requested therapeutic abortion, which was done; it is important to note that the abortion was regimens. In fact, in the majority of cases of MDR tuberculosis in Los Angeles County, the organisms have acquired multidrug not done to manage her MDR tuberculosis. Ethambutol was used to retreat patient 4 because susceptibility testing of an resistance through the patients' nonadherence to prior treatment regimens prescribed here or abroad [18] . Thus, DOT is vital organism obtained by culture of sputum collected during her first trimester had shown only borderline resistance to that drug for treatment of MDR tuberculosis and prevention of its development (especially in patients who have demonstrated prior at the lowest level tested. On termination of their pregnancies, all four patients were given complete retreatment regimens noncompliance or whose organisms are already resistant to either isoniazid or rifampin). The role of physician error in the by daily DOT to assure adherence to treatment and prevent development of additional drug resistance. development of multidrug resistance is illustrated by case 3.
/ 9c68$$ju37 05-11-99 12:36:55 cida UC: CID Patients 1 -3 were considered infectious during delivery, receiving her prior retreatment regimen, and she had considerable anxiety and depression because of concern that she had since all had had recent sputa demonstrating AFB on smears. During the perinatal period, adherence to the infection-control relapsed with MDR tuberculosis. Investigation of contacts was repeated. However, restriction fragment length polymorphism guidelines described by the CDC [11] was successful in preventing perinatal aerosol transmission of MDR tuberculosis to analysis proved that the single specimen collected from patient 1 during hospitalization for hemoptysis that was positive by the health care workers and neonates. It is important to note that one of the key components of preventing transmission was smear and culture had a pattern identical to that of an organism from another patient. The specimen of patient 1 was probably communication of specific infection-control procedures to all members of the patient care team, including obstetricians, anesmislabeled after collection on the ward, and this incident demonstrates the negative therapeutic impact of accepting laborathesiologists, pediatricians, and nurses in the labor and delivery rooms and on the ward. All housestaff and attending physicians tory-related data per se [23] . Four months later, patient 1 had a spontaneous right pneumothorax that eventually resolved after on rotation during the patients' confinement periods were notified of the management needs of each patient, since any one surgical resection of a ruptured right apical bleb. Her course demonstrates the complications of chronic cavitary tuberculoof several teams was likely to be on call on the delivery date. Ongoing tuberculosis screening of the health care workers and sis, which include pneumothorax (possibly due to erosion of a cavitary lesion connecting the tracheobronchial tree with the follow-up testing after their involvement with the patients with MDR tuberculosis were important administrative components pleural space), bleb formation (due to air trapping in an acinus or subsegment), empyema (due to rupture of an infected cavity of the infection-control plan, as it was then possible to determine whether tuberculosis transmission had occurred.
or bleb into the pleural space), bronchiectasis, hemoptysis, and superinfection of the cavitary lesion [24] . Some of these comThe neonates of patients 1 and 2 were immunized with BCG according to CDC guidelines because it was initially unclear plications may occur even after the tuberculosis has been successfully treated. whether retreatment would render their mothers noncontagious [21] . Although BCG may be effective in preventing tuberculoMedical and surgical therapies for MDR tuberculosis can also cause complications. Patient 1 developed hearing impairsis infection from progressing to potentially fatal tuberculosis in neonates, its overall efficacy was estimated to be 50% [22] . ment after receiving streptomycin, kanamycin, and capreomycin during prior failed retreatment regimens. Although many BCG may result in tuberculin reactivity, making it difficult to determine whether a positive skin test result of a vaccine recipiantituberculosis medications can cause adverse effects that may be irreversible, only patient 1 had permanent treatment-related ent is due to tuberculosis infection or to a booster response [21] . The benefits of BCG must therefore be balanced against end-organ damage. Patient 2 underwent right pneumonectomy to remove a lung destroyed by chronic tuberculosis; she subsethe risks of compromising the utility of future tuberculin skin testing as a surveillance tool. Although there was no evidence quently developed an infected bronchopleural fistula, requiring creation of an Eloesser flap. Clearly, MDR tuberculosis treatof peripartum transmission of MDR tuberculosis to either the neonates or health care workers, the child of patient 1 had a ment courses are seldom uncomplicated and benign. Finally, these cases emphasize the need for health care propositive tuberculin skin testing result (after previous negative results) long after the patient became noncontagious, and the viders to remember that pregnancy is always a possibility for women in their reproductive years. Prior treatment courses of child of patient 2 was subsequently exposed to another household member who, because of nonadherence to prior preventive both patients 1 and 2 were interrupted because of intercurrent pregnancies, and patient 3 had two pregnancies while being therapy, progressed to cavitary smear-positive tuberculosis. Booster reactions could not be completely ruled out, because treated for MDR tuberculosis despite repeated counseling to use contraception diligently during this time. Each of our patients the infants of patients 1 and 2 had been immunized with BCG. However, the increase in the size of subsequent tuberculin acquired multidrug resistance from prior nonadherence to treatment, and this pattern of behavior may indicate a higher risk skin test results indicated possible tuberculosis transmission, supported by epidemiologic evidence in the infant of patient of failure to use contraception regularly. Thus, pregnant patients with acquired MDR tuberculosis must be counseled about 2. Additionally, the firstborn of patient 3 had a positive tuberculin skin test result after previous negative ones before the birth the teratogenic risks of some antituberculosis drugs, and repeated counseling and assistance with obtaining contraception of the patient's second child. These cases emphasize the high risk of tuberculosis transmission in certain populations and the are indicated, even after a current pregnancy ends and retreatment with potentially toxic drugs begins. need for education and heightened surveillance in these groups.
Posttreatment complications resulting from long-standing In conclusion, pregnancy complicates the management of concurrent MDR tuberculosis, since the decision to treat must pulmonary MDR tuberculosis or treatment deserve comment. After completing 24 months of retreatment after cultures began take into account the risks of vertical and lateral tuberculosis transmission, disease progression, and adverse drug effects. yielding negative results, patient 1 had hemoptysis that was initially attributed to relapsed MDR tuberculosis, since a spuHowever, this case series demonstrates that MDR tuberculosis in pregnancy can be successfully and safely managed. Such tum smear was positive for AFB. The patient again began / 9c68$$ju37 05-11-99 12:36:55 cida UC: CID
